1. |
Peto P, Salama AD. Update on antiglomerular basement membrane disease [J]. Curr Opin Rheumatol, 2011, 23(1): 32.
|
2. |
Cui Z, Zhao MH. Advances in human antiglomerular basement membrane disease [J]. Nat Rev Nephrol, 2011, 7(12): 697-705.
|
3. |
Levy JB, Turner AN, Rees A J, et al. Long-term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression[J]. Ann Intern Med, 2001, 134(11): 1033-1042.
|
4. |
Jayne DRW, Gaskin G, Rasmussen N, et al. Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis[J]. J Am Soc Nephrol, 2007, 18(7): 2180-2188.
|
5. |
Cui Z, Zhao J, Jia X, et al. Anti-glomerular basement membrane disease: outcomes of different therapeutic regimens in a large single-center chinese cohort study[J]. Medicine, 2011, 90(5): 303.
|
6. |
Kidney Disease: Improving GlobalOutcomes(KDIGO) Glomerulonephritis Work Group. KDIGO clinical practice guideline for glomerulonephritis[J]. Kidney Int, 2012, 2(Supp l): 139-274.
|